Last A$0.0070 AUD
Change Today 0.00 / 0.00%
Volume 2.7M
As of 12:10 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

bone medical ltd (BNE) Snapshot

Open
A$0.0070
Previous Close
A$0.0070
Day High
A$0.0080
Day Low
A$0.0070
52 Week High
11/28/13 - A$0.10
52 Week Low
01/24/14 - A$0.0050
Market Cap
1.8M
Average Volume 10 Days
3.1M
EPS TTM
A$-0.04
Shares Outstanding
257.8M
EX-Date
03/6/97
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BONE MEDICAL LTD (BNE)

Related News

No related news articles were found.

bone medical ltd (BNE) Related Businessweek News

No Related Businessweek News Found

bone medical ltd (BNE) Details

Bone Medical Ltd, a specialty biopharmaceutical company, develops therapeutics to prevent and/or treat bone and joint diseases and conditions, primarily osteoporosis, osteoarthritis, and rheumatoid arthritis in Australia. The company’s product pipeline consists of Phase II clinical-stage programs and four preclinical programs. Its principal products include CaPTHymone, an oral parathyroid hormone for the treatment of osteoporosis; Capsitonin, an oral calcitonin for the treatment of osteoarthritis pain; and BN006, a synthetic oligopeptide with selective TNF-a and IL-6 inhibitory mechanism and the potential for oral administration. The company also develops BN005/BN008 cell regulators for the treatment of osteoporosis and arthritis. Bone Medical Ltd is based in West Perth, Australia.

bone medical ltd (BNE) Top Compensated Officers

Senior Consultant
Total Annual Compensation: A$135.7K
Compensation as of Fiscal Year 2014.

bone medical ltd (BNE) Key Developments

Bone Medical Ltd. Announces Consolidated Earnings Results for the Year Ended June 30, 2014

Bone Medical Ltd. announced consolidated earnings results for the year ended June 30, 2014. For the period, the company reported total revenue of AUD 16,844 compared to AUD 5 a year ago. Loss before income tax expense was AUD 1,231,319 compared to AUD 1,849,884 a year ago. Loss after income tax for the year was AUD 1,131,036 compared to AUD 1,849,884 a year ago. Basic and diluted LPS was 0.91 cents compared to 0.291 cents a year ago. Net cash used in operating activities was AUD 1,290,368 compared to AUD 1,039,860 a year ago.

Bone Medical Limited Announces BN006 Research Collaboration with William Harvey Research Limited

Bone Medical Limited announced that it has entered into a research agreement with William Harvey Research Limited (WHRL), to further study the company's novel anti-inflammatory molecule for rheumatoid arthritis (RA), BN006, and support its progress towards clinical studies in man. The collaboration is funded under Bone Medical's recently completed recapitalization and the results will potentially position BN006 for Phase 1 human trials in the near future.

Bone Medical Ltd. Replaces Mark Clements with Phillip Wingate as Company Secretary; Changes Registered Office Address

Bone Medical Ltd. announced that Mr. Mark Clements has resigned from the position of Company Secretary. Mr. Phillip Wingate has been appointed as Company Secretary of the company following Mr. Clements resignation. The company also announced that the registered office changed to Ground Floor, 16 Ord Street, West Perth WA 6005.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BNE:AU A$0.01 AUD 0.00

BNE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BNE.
View Industry Companies
 

Industry Analysis

BNE

Industry Average

Valuation BNE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BONE MEDICAL LTD, please visit www.bone-ltd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.